NASDAQ · Financial Statements
Pyxis Oncology, Inc. (PYXS) Financial Statements
$2.03
NASDAQ: PYXS
Market Cap $128.61M
Overview Financials Dividend Pyxis Oncology, Inc. most recently reported annual revenue of $14.0M, net profit of $-80.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $16.0M $14.0M Operating Profit $-70.0M $-123.0M $-82.0M $-89.0M $-84.0M Net Profit $-76.0M $-121.0M $-74.0M $-77.0M $-80.0M EPS $-2.53 $-3.57 $-1.85 $-1.32 $-1.28 Op Margin — — — -554.1% -609.2%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $280.0M $211.0M $174.0M $157.0M $92.0M Total Liabilities $19.0M $51.0M $48.0M $36.0M $38.0M Cash $275.0M $179.0M $10.0M $19.0M $15.0M Borrowings $0 $19.0M $21.0M $20.0M $19.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-35.0M $-89.0M $-71.0M $-58.0M $-64.0M Investing Cash Flow $-1.0M $-13.0M $-112.0M $8.0M $59.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $268.0M $-96.0M $-170.0M $10.0M $-4.0M Free Cash Flow $-36.0M $-96.0M $-77.0M $-58.0M $-64.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.20 EV / EBITDA -1.61 FCF Yield -50.09% Quick Ratio 1.34 Interest Coverage 0.00 Return 1Y 92.44% Return 3Y -13.58% Return 5Y —
Screens featuring this stock